Kera Capital Partners, Inc. Abbott Laboratories Transaction History
Kera Capital Partners, Inc.
- $483 Million
- Q2 2025
A detailed history of Kera Capital Partners, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Kera Capital Partners, Inc. holds 2,583 shares of ABT stock, worth $342,428. This represents 0.07% of its overall portfolio holdings.
Number of Shares
2,583
Previous 2,321
11.29%
Holding current value
$342,428
Previous $308 Million
99.89%
% of portfolio
0.07%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,602Shares Held
1.4BCall Options Held
9.23MPut Options Held
8.1M-
Vanguard Group Inc Valley Forge, PA173MShares$22.9 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.4MShares$10.4 Billion0.41% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.97 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.54 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $232B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...